Sep 2026· Diabetes, obesity and metabolism· Vol 28, pp. 11821 - 11827· 0 citations· 28 references
Medicine
Abstract
Rare GCK variants contribute to heterogeneous forms of monogenic diabetes, yet the molecular basis underlying their diverse functional consequences and pharmacological responsiveness remains incompletely understood. As glucokinase (GCK) serves as a central glucose sensor in pancreatic β‐cells and hepatocytes, defining the functional properties of individual variants may improve molecular diagnosis and inform the interpretation of potential therapeutic responses in GCK‐maturity‐onset diabetes of the young (GCK‐MODY, also called MODY2).
Glucose homeostasis depends on coordinated genetic and epigenetic regulation of pancreatic beta-cells, insulin-sensitive tissues, and neuroendocrine circuits. This review synthesises evidence from over 600 GWAS loci and the primary literature published between 2008 and 2026, and emerging single-cell functional genomics...
Manoj Khokhar· npj Metabolic Health and Dis...· 0 citations
Autoimmune diseases are clinically heterogeneous, and patients who share a diagnosis often diverge in outcome and drug response, yet conventional biomarkers capture only part of this variation. This feature article explores how metabolomics, the molecular readout closest to the phenotype, can strengthen precision medic...
This review evaluates pharmacogenomic evidence across monogenic and polygenic diabetes subtypes, presents Indian clinical case studies demonstrating the consequences of genomic misclassification, and positions GLIS3 as an underexplored regulatory gene with cross-disease relevance spanning neonatal diabetes, Type 1, and...
A. Lenin, Jasmin Sajini Rajayan· Frontiers in Endocrinology· 0 citations
Inherited platelet disorders (IPDs) are caused by pathogenic variants in genes responsible for megakaryocyte and platelet biology, leading to qualitative and quantitative platelet defects. Advances in high-throughput sequencing plus variant-curation expertise and detailed clinical evaluation have led to the identificat...
I. Eldem, J. Di Paola· Hematology/Oncology Clinics...· 0 citations
Rare diseases affect hundreds of millions of individuals worldwide, primarily resulting from genetic factors, with many presenting during childhood. Advances in genome sequencing increasingly enable identification of the responsible gene in more patients; however, only a limited selection of therapies exists to correct...
S. Niazi· Communications Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.